On ECHEMI
Home > Drugs > diabetes
diabetes
Diabetes is a common disease caused by the interaction of genetic and environmental factors. The main clinical sign is high blood sugar. Common symptoms include polydipsia, polyuria, polyphagia, and weight loss. Diabetes can cause damage to multiple systems in the body, leading to absolute or relative insulin deficiency and reduced insulin sensitivity of target tissue cells, causing a series of metabolic disorders such as protein, fat, water, and electrolytes. Significant increase in blood sugar can cause acute complications such as diabetic ketoacidosis and hyperosmolar coma. Long-term illness can also cause vascular and neuropathy, resulting in damage to multiple organs and tissues such as the heart, brain, kidneys, eyes, nerves, and skin, affecting the patient's quality of life and even shortening life expectancy. Active prevention and treatment should be carried out.
Related Drugs
Tolbutamide Tablets
Indication: It is suitable for mild and moderate type 2 diabetes mellitus that is not effectively controlled by diet alone. The patient's pancreatic β cells have a certain insulin secretion function and there are no serious complications.
Manufacturer:

Liaoning PHARMA-UNION Pharmaceutical Co., Ltd.

Tolbutamide Tablets
Indication: It is suitable for mild and moderate type 2 diabetes mellitus that is not effectively controlled by diet alone. The patient's pancreatic β cells have a certain insulin secretion function and there are no serious complications.
Tolbutamide Tablets
Indication: It is suitable for mild and moderate type 2 diabetes mellitus that is not effectively controlled by diet alone. The patient's pancreatic β cells have a certain insulin secretion function and there are no serious complications.
Manufacturer:

Shanghai HENGYUAN (Chuanhui) Nuoke Pharm Area Tical Co., Ltd.

Tolbutamide Tablets
Indication: It is suitable for mild and moderate type 2 diabetes mellitus that is not effectively controlled by diet alone. The patient's pancreatic β cells have a certain insulin secretion function and there are no serious complications.
Manufacturer:

Beijing Shuguang Pharm Co., Ltd.

Metformin and Glibenclamide Tablets (I)
Indication: 1. For patients with type 2 diabetes whose blood sugar levels are not satisfactorily controlled by simple diet control and/or exercise therapy. 2. Can be used as a second-line medication for patients with type 2 diabetes whose blood sugar levels are not satisfactorily controlled by single sulfonylurea or metformin hydrochloride therapy.
Manufacturer:

Hainan Simcere Pharmaceutical Co., Ltd.

Compound theophylline and ephedrine tablets
Indication: Use with caution in patients with diabetes or glucose metabolism disorders.
Manufacturer:

Yingkou AODA Pharmaceuticals Co., Ltd.

Pentoxifylline Sodium Chloride Injection
Indication: 1. Cerebral blood circulation disorders such as transient cerebral ischemic attack, sequelae of stroke, and brain dysfunction caused by cerebral ischemia; 2. Peripheral blood circulation disorders such as thromboembolic vasculitis, abdominal arterial blood circulation disorders, intermittent claudication or rest pain; 3. Inner ear circulation disorders such as sudden deafness, senile tinnitus and deafness; ④ Ocular blood circulation disorders such as diabetic retinal artery embolism.
Manufacturer:

Shandong Fenghuang Pharmaceutical Co., Ltd.

Pentoxifylline Sodium Chloride Injection
Indication: 1. Cerebral blood circulation disorders such as transient cerebral ischemic attack, sequelae of stroke, and brain dysfunction caused by cerebral ischemia; 2. Peripheral blood circulation disorders such as thromboembolic vasculitis, abdominal arterial blood circulation disorders, intermittent claudication or rest pain; 3. Inner ear circulation disorders such as sudden deafness, senile tinnitus and deafness; 4. Ocular blood circulation disorders such as diabetic retinal artery embolism.
Cilostazol Tablets
Indication: 1. This product has vasodilation and antiplatelet effects, and can be used to treat chronic arterial occlusive disease caused by atherosclerosis, large arteritis, thromboangiitis obliterans, and diabetes; 2. This product can improve chronic ulcers, pain, chills, and intermittent claudication caused by limb ischemia, and can be used as a supplementary treatment after surgical treatment of the above diseases (such as angioplasty, vascular transplantation, sympathectomy) to help relieve symptoms, improve circulation, and inhibit thrombosis in transplanted blood vessels.
Manufacturer:

Zhejiang Kinglyuan Pharmaceutical Co., Ltd.

Vitality source tablets
Manufacturer:

Xi'an Renren Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.